Eisai’s lenvatinib sNDA receives FDA Priority Review for potential treatment of patients with advanced RCC

Posted in: Medical Condition News | Pharmaceutical News

Tags: Abdominal Pain, Alzheimer’s Disease, Angiogenesis, Antibody, Arthralgia, Blood, Blood Pressure, Breastfeeding, Calcium, Cancer, Carcinoma, Cell, Contraception, Diarrhea, Drugs, Dysphonia, Electrolyte, Epilepsy, Epistaxis, Everolimus, Fatigue, Fertility, Fibroblast, Fistula, Headache, Health Care, Hypertension, Hypocalcemia, Kidney Cancer, Kinase Inhibitor, Long QT Syndrome, Metastasis, Nausea, Neuroscience, New Drug Application, Nursing, Oncology, Pain, Placebo, Proteinuria, Renal Cell Carcinoma, Renal Failure, Stomatitis, Thyroid, Thyroid Cancer, Tumor, Tyrosine, Vascular Endothelial Growth Factor, VEGF, Vomiting